WordNet

Kamarupan languages spoken in northeastern India and western Burma

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. ホスホグリセリン酸キナーゼ欠損症およびホスホグリセリン酸ムターゼ欠損症phosphoglycerate kinase deficiency and phosphoglycerate mutase deficiency [show details]
…Human PGAM is a dimer consisting of different amounts of muscle (MM) isozyme, brain (BB) isozyme, and the intermediate hybrid (MB) isozyme. Inheritance is autosomal recessive. Various distinct point mutations…
2. アスピリン：リウマチ性疾患における作用機序、主な毒性、および使用aspirin mechanism of action major toxicities and use in rheumatic diseases [show details]
…site of aspirin and nonsalicylate NSAID binding . Mammalian cells contain two related but unique isozymes of COX: PG endoperoxide H2 synthase-1 and -2 (COX-1 and COX-2, respectively). Both catalyze the …
3. グリコーゲン代謝のその他の障害：GLUT2欠損症およびアルドラーゼA欠損症other disorders of glycogen metabolism glut2 deficiency and aldolase a deficiency [show details]
…#611881) is a rare GSD associated with hereditary hemolytic anemia. In the glycolytic pathway, three isozymes of aldolase (A, B, and C) are responsible for the conversion of fructose-1,6-biphosphate into g …
4. 家族性アルドステロン症familial hyperaldosteronism [show details]
…the zona fasciculata. Two isozymes of 11-beta-hydroxylase encoded by two genes on chromosome 8 are responsible for the biosynthesis of aldosterone and cortisol : The isozyme in the zona glomerulosa (CYP11B2 …
5. 筋ホスホリラーゼ欠損症（糖原病V型、マッカードル病）myophosphorylase deficiency glycogen storage disease v mcardle disease [show details]
…been shortened to approximately 4 glucosyl units. Glycogen phosphorylase exists in three distinct isozymes (muscle [PYGM], liver [PYGL], and brain [PYGB]), but diseases are only described for muscle and …

English Journal

Safety and effectiveness of enzyme replacement therapy with agalsidase alfa in patients with Fabry disease: Post-marketing surveillance in Japan.

Sasa H, Nagao M, Kino K.
Molecular genetics and metabolism. 2019 04;126(4)448-459.
Fabry disease is a rare X-linked inherited multisystem disorder resulting from deficiency of the lysosomal enzyme alpha-galactosidase A. Currently, specific therapies, including enzyme replacement therapies, are available for Fabry disease, but clinical trials provide limited information on long-ter
PMID 30803893

Regional Spread of CTX-M-2-Producing Proteus mirabilis with the Identical Genetic Structure in Japan.

Kato K, Matsumura Y, Yamamoto M, Nagao M, Takakura S, Ichiyama S.
Microbial drug resistance (Larchmont, N.Y.). 2017 Jul;23(5)590-595.
In this study, we analyzed the molecular epidemiology of extended-spectrum β-lactamase (ESBL)-producing Proteus mirabilis isolates collected from the central region of Japan. Between 2005 and 2012, 820 clinical P. mirabilis isolates were obtained from ten acute care hospitals in Japan. We character
PMID 27834610

Evaluating the Risk of a Fifth Metatarsal Stress Fracture by Measuring the Serum 25-Hydroxyvitamin D Levels.

Shimasaki Y, Nagao M, Miyamori T, Aoba Y, Fukushi N, Saita Y, Ikeda H, Kim SG, Nozawa M, Kaneko K, Yoshimura M.
Foot & ankle international. 2016 Mar;37(3)307-11.
The fifth metatarsal bone is a common site of stress fractures in soccer athletes. Although several endocrine risk factors for stress fractures have been proposed, the endocrine risks for fifth metatarsal (5-MT) stress fractures have not been evaluated. To evaluate the endocrine risks of fifth metat
PMID 26596794

Japanese Journal

プレチラクロームや活性酸素により誘導されるGSTアイソザイムの比較

長尾明子,臼井健二,松本宏
雑草研究 43(3), 271-273, 1998-10-30
NAID 110003930725

<Abstract of Published Report>Effects of cAMP-phosphodiesterase Isozyme Inhibitor on Cytokine Production by Lipopolysaccharide-stimulated Human Peripheral Blood Mononuclear Cells.

Yomoaki YOSHIMURA,Chikako KURITA,Tomomi NAGAO,Eiseki USAMI,Toshiya NAKAO,Shino WATANABE,Joji KOBAYASHI,Futoshi YAMAZAKI,Hiroyuki TANAKA,Hiroichi NAGAI
岐阜藥科大學紀要 = The annual proceedings of Gifu College of Pharmacy (47), 74, 1998-06-30
NAID 120005563044

<Abstract of Published Report>Effects of cAMP-phosphodiesterase Isozyme Inhibitor on Cytokine Production by Lipopolysaccharide-stimulated Human Peripheral Blood Mononuclear Cells.

YOSHIMURA Yomoaki,KURITA Chikako,NAGAO Tomomi,USAMI Eiseki,NAKAO Toshiya,WATANABE Shino,KOBAYASHI Joji,YAMAZAKI Futoshi,TANAKA Hiroyuki,NAGAI Hiroichi
岐阜藥科大學紀要 47, 74, 1998-06-30
NAID 110000054090